A Phase 3 Multicenter, Event-Driven, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study, Evaluating the Effect of Study Medication Versus Placebo, Given Once Daily in Addition to Standard of Care, to Prevent the Progression of Chronic Kidney Disease on Renal Outcomes and Cardiovascular Mortality

August 17, 2018
https://clinicaltrials.gov/ct2/show/NCT03036150
Nephrology
Principal Investigator: Kausik Umanath, MD
Chronic Kidney Disease
Accepting Participants